Results 231 to 240 of about 678,448 (346)

Comparison of Carvedilol to Propranolol in Reduction of Hepatic Venous Pressure Gradient in Liver Cirrhosis: A Meta‐Analysis

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background Nonselective beta‐blockers, such as propranolol and carvedilol, are used to prevent first decompensation in patients with clinically significant portal hypertension. Methods We performed a systematic literature search of English language articles from inception in PubMed, Medline, and Cochrane databases to compare the effect of ...
Amey Joshi, Hafsa Arshad Azam Raja, Poulami Roy, Fakhar Latif, Rahul George Reji, Novonil Deb, Ryan K. Mui, Ahmed Shady   +7 more
wiley   +1 more source

A Case of Hepatic Encephalopathy With Diffuse Brainstem Signal Changes on Magnetic Resonance Imaging. [PDF]

Cureus
Yurimoto H, Matsubayashi T, Shibata I, Furuki M, Obayashi M.   +4 more
europepmc   +1 more source

The Role of Endoscopic Ultrasound in Assessing Portal Hypertension: A State‐of‐the‐Art Literature Review and Evolving Perspectives

Liver International, Volume 45, Issue 4, April 2025.
ABSTRACT Background Portal hypertension (PH) is a critical complication in patients with hepatic diseases. Its accurate evaluation is essential for early diagnosis, risk stratification, and management. Endoscopic ultrasound (EUS) has emerged as a promising diagnostic tool, offering high‐resolution imaging of the portal venous system, hepatic ...
Fabrizio Termite, Federica Borrelli de Andreis, Antonio Liguori, Antonio Gasbarrini, Fabia Attili, Cristiano Spada, Luca Miele   +6 more
wiley   +1 more source

Evaluation of Plasma Neurodegenerative Biomarkers for Diagnosing Minimal Hepatic Encephalopathy and Predicting Overt Hepatic Encephalopathy in Chinese Patients with Hepatic Cirrhosis. [PDF]

J Clin Transl Hepatol
Cheng Q, Liu Y, Yang Z, Zhang M, Liu T, Niu Y, Liu W, Huang L, Feng Y, Zhang X, Luo X, Ning Q, Chen T.   +12 more
europepmc   +1 more source

Microvesicle Tissue Factor Procoagulant Activity Is Elevated and Correlated With Disease Severity in Patients With Cirrhosis

Liver International, Volume 45, Issue 4, April 2025.
ABSTRACT Background and Aims Tissue factor‐expressing microvesicles (MV‐TF) have been found to correlate with thrombotic complications in various diseases. Simultaneously, there is expanding research regarding the effect of the coagulation cascade on liver fibrosis progression.
Adonis A. Protopapas, Anna Takardaki, Nefeli Protopapa, Ioanna Papagiouvanni, Andreas N. Protopapas, Lemonia Skoura, Christos Savopoulos, Ioannis Goulis   +7 more
wiley   +1 more source

Clinical Significance of Marginal Zinc Deficiency as a Predictor of Covert Hepatic Encephalopathy in Patients with Liver Cirrhosis. [PDF]

Int J Mol Sci
Matsuda T, Namisaki T, Shibamoto A, Asada S, Tomooka F, Kubo T, Koizumi A, Tanaka M, Iwai S, Inoue T, Tsuji Y, Fujinaga Y, Nishimura N, Sato S, Kitagawa K, Kaji K, Mitoro A, Asada K, Takaya H, Noguchi R, Akahane T, Yoshiji H.   +21 more
europepmc   +1 more source

Severe Dietary Energy Restriction for Compensated Cirrhosis Due to Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Randomised Controlled Trial

Journal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 3, June 2025.
ABSTRACT Background Compensated cirrhosis due to metabolic dysfunction‐associated steatotic liver disease (CC‐MASLD) increases morbidity and mortality risk but has no aetiology‐specific treatment. We investigated the safety and efficacy signals of severe energy restriction.
Dimitrios A. Koutoukidis, Susan A. Jebb, Jeremy W. Tomlinson, Ferenc E. Mozes, Michael Pavlides, Miriam Lacharie, Francesca Saffioti, Paul Aveyard, Jeremy F. Cobbold   +8 more
wiley   +1 more source

QuickStroop for screening for minimal hepatic encephalopathy in patients with cirrhosis. [PDF]

JHEP Rep
Labenz C, Gairing SJ, Kaps L, Ehrenbauer AF, Schleicher EM, Mengel S, Egge JFM, Gabriel MM, Galle PR, Wedemeyer H, Zipprich A, Ripoll C, Greinert R, Maasoumy B.   +13 more
europepmc   +1 more source

Integrated Multiomics Analyses of the Molecular Landscape of Sarcopenia in Alcohol‐Related Liver Disease

Journal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 3, June 2025.
ABSTRACT Background Skeletal muscle is a major target for ethanol‐induced perturbations, leading to sarcopenia in alcohol‐related liver disease (ALD). The complex interactions and pathways involved in adaptive and maladaptive responses to ethanol in skeletal muscle are not well understood.
Nicole Welch, Pugazhendhi Kannan, Saurabh Mishra, Annette Bellar, Vandana Agrawal, Grahame Kidd, Emily Benson, Ryan Musich, Raya Tabbalat, Ling Li, J. Mark Brown, Belinda Willard, Karyn A. Esser, Laura E. Nagy, Srinivasan Dasarathy   +14 more
wiley   +1 more source

Smartphone-based Stroop Test, EncephalApp: What is the optimal cutoff for diagnosing minimal hepatic encephalopathy? [PDF]

World J Hepatol
Masuzaki R, Kogure H.
europepmc   +1 more source